MRI-compatible intraoperative robotics developer AiM Medical Robotics announced today that it raised $3.4 million in a seed funding round.
Fort Lauderdale, Florida–based AiM Medical Robotics designed its robotic platform to be cost-efficient, streamlined and differentiated in its ability to improve outcomes for those undergoing neurosurgery for functional brain disorders such as Parkinson’s and epilepsy, as well as cancer.
The company said in a news release that it plans to use the funds to accelerate the development of its MRI-compatible neurosurgery platform and to grow its team across research, engineering and clinical and medical affairs.
“AiM is on an exciting journey to develop and commercialize an industry-first in robot-assisted surgery with our MRI-compatible robotics platform,” AiM CEO Bob Cathcart said in the release. “I am honored to have the support of our investors as we continue building our team of experts in robotics and medicine, and as we work towards our north star of improving patient outcomes in neurosurgery.”
IQ Capital and Surrey Capital Partners led the funding round, with Surrey founder Samantha SUrrey joining AiM’s board of directors. Other investors include the Lambda Fund, Triple Ring Technologies and Worcester Polytechnic Institute, among additional inside investors.
